Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia
- PMID: 26476205
- DOI: 10.1016/j.bbmt.2015.10.006
Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia
Abstract
To investigate an up-to-date alternative donor selection strategy, we compared the transplantation outcomes of 8/8 and 7/8 allele-matched unrelated bone marrow transplantation (UBMT) with those of umbilical cord blood transplantation (UCBT) and redefined the role of UCBT with extended analysis. Using Cox and competing risk regression analyses, we analyzed the transplantation outcomes in adult patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). A total of 2472 first myeloablative transplantations between 2000 and 2010 were included (8/8 UBMT, 1001; 7/8 UBMT, 656; UCBT, 815). For acute and chronic graft-versus-host disease (GVHD) and nonrelapse mortality (NRM), we applied the combined analyses including both AML and ALL data. In the multivariate analyses, severe acute GVHD and NRM after UCBT were comparable with 8/8 UBMT, whereas those after 7/8 UBMT were significantly higher. The incidence of extensive chronic GVHD was significantly lower with UCBT compared with after 8/8 and 7/8 UBMT. With adjusted analyses for AML, UCBT and 8/8 UBMT showed similar overall survival (OS), whereas 7/8 UBMT showed inferior OS. For ALL, we found no significant difference in OS among the 3 groups. Cord blood may be the first choice alternative to 8/8 UBMT for both AML and ALL.
Keywords: Bone marrow transplantation; Graft source; Umbilical cord blood transplantation; Unrelated volunteer donor.
Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.Chin Med J (Engl). 2013 Jul;126(13):2499-503. Chin Med J (Engl). 2013. PMID: 23823825
-
Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia.Biol Blood Marrow Transplant. 2020 Nov;26(11):2105-2114. doi: 10.1016/j.bbmt.2020.08.001. Epub 2020 Aug 9. Biol Blood Marrow Transplant. 2020. PMID: 32784070
-
A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia.Biol Blood Marrow Transplant. 2016 Oct;22(10):1836-1843. doi: 10.1016/j.bbmt.2016.07.002. Epub 2016 Jul 8. Biol Blood Marrow Transplant. 2016. PMID: 27401034
-
A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients.Biol Blood Marrow Transplant. 2012 Aug;18(8):1164-73. doi: 10.1016/j.bbmt.2012.01.015. Epub 2012 Jan 28. Biol Blood Marrow Transplant. 2012. PMID: 22289799 Review.
-
A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients.Biol Blood Marrow Transplant. 2007 Apr;13(4):444-53. doi: 10.1016/j.bbmt.2006.11.005. Epub 2007 Feb 15. Biol Blood Marrow Transplant. 2007. PMID: 17382250 Review.
Cited by
-
Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation.Bone Marrow Transplant. 2017 Feb;52(2):323-325. doi: 10.1038/bmt.2016.278. Epub 2016 Nov 7. Bone Marrow Transplant. 2017. PMID: 27819686 No abstract available.
-
Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.Bone Marrow Transplant. 2020 Jul;55(7):1430-1437. doi: 10.1038/s41409-020-0853-1. Epub 2020 Mar 11. Bone Marrow Transplant. 2020. PMID: 32161321
-
Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol.Medicine (Baltimore). 2018 Apr;97(17):e0449. doi: 10.1097/MD.0000000000010449. Medicine (Baltimore). 2018. PMID: 29702996 Free PMC article. Clinical Trial.
-
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.Curr Treat Options Oncol. 2021 Jun 7;22(7):63. doi: 10.1007/s11864-021-00860-1. Curr Treat Options Oncol. 2021. PMID: 34097131 Review.
-
GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.Bone Marrow Transplant. 2017 Sep;52(9):1261-1267. doi: 10.1038/bmt.2017.116. Epub 2017 Jun 12. Bone Marrow Transplant. 2017. PMID: 28604665
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical